Aligned Genetics Inc
238120
Company Profile
Business description
Aligned Genetics Inc is engaged in a technology venture company that develops, manufactures, and sells cutting-edge equipment and reagents for life science research and diagnostics. Its main products are categorized into three categories: automatic cell counting systems, biological tissue transparency and imaging systems, and digital cell imaging systems.
Contact
28, Simindae-ro 327beongil, Gwanyang-dong
3rd floor
Dongan-gu, Gyeonggi-do
Anyang-si
KORT: +82 314784185
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
69
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,322.30 | 38.50 | 0.41% |
| CAC 40 | 8,174.20 | 14.39 | -0.18% |
| DAX 40 | 23,830.99 | 441.20 | -1.82% |
| Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
| FTSE 100 | 9,354.57 | 81.52 | -0.86% |
| HKSE | 25,854.98 | 607.88 | 2.41% |
| NASDAQ | 22,679.97 | 117.44 | 0.52% |
| Nikkei 225 | 48,899.56 | 1,317.41 | 2.77% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,664.01 | 34.94 | 0.53% |
| S&P/ASX 200 | 9,030.10 | 41.90 | 0.47% |
| SSE Composite Index | 3,866.09 | 26.34 | 0.69% |